2,451
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

The era of Cas12 and Cas13 CRISPR-based disease diagnosis

, , & ORCID Icon
Pages 714-729 | Received 12 Aug 2021, Accepted 20 Dec 2021, Published online: 15 Feb 2022

References

  • Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DBT, Shmakov S, Makarova KS, Semenova E, Minakhin L, et al. 2016. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 353:6299.
  • Ackerman CM, Myhrvold C, Thakku SG, Freije CA, Metsky HC, Yang DK, Ye SH, Boehm CK, Kosoko-Thoroddsen T-SF, Kehe J, et al. 2020. Massively multiplexed nucleic acid detection with Cas13. Nature. 582(7811):277–282.
  • Ai J-W, Zhou X, Xu T, Yang M, Chen Y, He G-Q, Pan N, Cai Y, Li Y, Wang X, et al. 2019. CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis. Emerg Microbes Infect. 8(1):1361–1369.
  • Ali Z, Aman R, Mahas A, Rao GS, Tehseen M, Marsic T, Salunke R, Subudhi AK, Hala SM, Hamdan SM, et al. 2020. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Res. 288:198129.
  • Alon DM, Hak H, Bornstein M, Pines G, Spiegelman Z. 2021. Differential detection of the Tobamoviruses Tomato Mosaic Virus (ToMV) and Tomato Brown Rugose Fruit Virus (ToBRFV) using CRISPR-Cas12a. Plants. 10(6):1256.
  • Aman R, Mahas A, Marsic T, Hassan N, Mahfouz MM. 2020. Efficient, rapid, and sensitive detection of plant RNA viruses with one-pot RT-RPA–CRISPR/Cas12a assay. Front Microbiol. 11:3277.
  • Arizti-Sanz J, Freije CA, Stanton AC, Petros BA, Boehm CK, Siddiqui S, Shaw BM, Adams G, Kosoko-Thoroddsen T-SF, Kemball ME, et al. 2020. Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2. Nat Commun. 11(1):1–9.
  • Bai J, Lin H, Li H, Zhou Y, Liu J, Zhong G, Wu L, Jiang W, Du H, Yang J, et al. 2019. Cas12a-based on-site and rapid nucleic acid detection of African swine fever. Front Microbiol. 10:2830.
  • Bai Y, Zhao H. 2018. Liquid biopsy in tumors: opportunities and challenges. Ann Transl Med. 6(S1):S89–S89.
  • Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 315(5819):1709–1712.
  • Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M. 2019. Proteomics biomarkers for solid tumors: current status and future prospects. Mass Spectrom Rev. 38(1):49–78.
  • Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. 2005. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading). 151(Pt 8):2551–2561.
  • Borrebaeck CA. 2017. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat Rev Cancer. 17(3):199–204.
  • Bouzid D, Zanella M-C, Kerneis S, Visseaux B, May L, Schrenzel J, Cattoir V. 2021. Rapid diagnostic tests for infectious diseases in the emergency department. Clin Microbiol Infect. 27(2):182–191.
  • Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC. 2009. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res. 104(10):1184–1191.
  • Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, Miao X, Streithorst JA, Granados A, Sotomayor-Gonzalez A, et al. 2020. CRISPR–Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 38(7):870–874.
  • Cao Y, Wu J, Pang B, Zhang H, Le XC. 2021. CRISPR/Cas12a-mediated gold nanoparticle aggregation for colorimetric detection of SARS-CoV-2. Chem Commun (Camb). 57(56):6871–6874.
  • Chaijarasphong T, Thammachai T, Itsathitphaisarn O, Sritunyalucksana K, Suebsing R. 2019. Potential application of CRISPR-Cas12a fluorescence assay coupled with rapid nucleic acid amplification for detection of white spot syndrome virus in shrimp. Aquaculture. 512:734340.
  • Chan KCA, Woo JKS, King A, Zee BCY, Lam WKJ, Chan SL, Chu SWI, Mak C, Tse IOL, Leung SYM, et al. 2017. Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 377(6):513–522.
  • Chang Y, Deng Y, Li T, Wang J, Wang T, Tan F, Li X, Tian K. 2020. Visual detection of porcine reproductive and respiratory syndrome virus using CRISPR-Cas13a. Transbound Emerg Dis. 67(2):564–571.
  • Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA. 2018. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 360(6387):436–439.
  • Chen Q, Tian T, Xiong E, Wang P, Zhou X. 2020. CRISPR/Cas13a signal amplification linked immunosorbent assay for femtomolar protein detection. Anal Chem. 92(1):573–577.
  • Choi J-H, Lim J, Shin M, Paek S-H, Choi J-W. 2021. CRISPR-Cas12a-based nucleic acid amplification-free DNA biosensor via Au nanoparticle-assisted metal-enhanced fluorescence and colorimetric analysis. Nano Lett. 21(1):693–699.
  • Corcoran RB, Chabner BA. 2018. Application of cell-free DNA analysis to cancer treatment. N Engl J Med. 379(18):1754–1765.
  • Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, et al. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 25(3):2000045.
  • Crone MA, Priestman M, Ciechonska M, Jensen K, Sharp DJ, Anand A, Randell P, Storch M, Freemont PS. 2020. A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics. Nat Commun. 11(1):1–11.
  • Cunningham CH, Hennelly CM, Lin JT, Ubalee R, Boyce RM, Mulogo EM, Hathaway N, Thwai KL, Phanzu F, Kalonji A, et al. 2021. A novel CRISPR-based malaria diagnostic capable of Plasmodium detection, species differentiation, and drug-resistance genotyping. EBioMedicine. 68:103415.
  • De la Torre D, Mafla E, Puga B, Erazo L, Astolfi-Ferreira C, Ferreira AP. 2018. Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador. Vet World. 11(4):480–487.
  • de Puig H, Lee RA, Najjar D, Tan X, Soenksen LR, Angenent-Mari NM, Donghia NM, Weckman NE, Ory A, Ng CF, et al. 2021. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci Adv. 7(32):eabh2944.
  • Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 471(7340):602–607.
  • Ding X, Yin K, Li Z, Sfeir MM, Liu C. 2021. Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay. Biosens Bioelectron. 184:113218.
  • Fishman JA. 2017. Infection in organ transplantation. Am J Transplant. 17(4):856–879.
  • Fozouni P, Son S, Díaz de León Derby M, Knott GJ, Gray CN, D'Ambrosio MV, Zhao C, Switz NA, Kumar GR, Stephens SI, et al. 2021. Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy. Cell. 184(2):323–333.
  • Freije CA, Myhrvold C, Boehm CK, Lin AE, Welch NL, Carter A, Metsky HC, Luo CY, Abudayyeh OO, Gootenberg JS, et al. 2019. Programmable inhibition and detection of RNA viruses using Cas13. Mol Cell. 76(5):826–837.
  • Garneau JE, Dupuis M-È, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 468(7320):67–71.
  • Gong S, Yu HH, Johnson KA, Taylor DW. 2018. DNA unwinding is the primary determinant of CRISPR-Cas9 activity. Cell Rep. 22(2):359–371.
  • Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F. 2018. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 360(6387):439–444.
  • Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA, et al. 2017. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 356(6336):438–442.
  • Guo L, Sun X, Wang X, Liang C, Jiang H, Gao Q, Dai M, Qu B, Fang S, Mao Y, et al. 2020. SARS-CoV-2 detection with CRISPR diagnostics. Cell Discov. 6(1):1–4.
  • He Q, Yu D, Bao M, Korensky G, Chen J, Shin M, Kim J, Park M, Qin P, Du K, et al. 2020. High-throughput and all-solution phase African Swine Fever Virus (ASFV) detection using CRISPR-Cas12a and fluorescence based point-of-care system. Biosens Bioelectron. 154:112068.
  • He Y, Wu Y, Wang Y, Wang X, Xing S, Li H, Guo S, Yu X, Dai S, Zhang G, et al. 2020. Applying CRISPR/Cas13 to construct exosomal PD‐L1 ultrasensitive biosensors for dynamic monitoring of tumor progression in immunotherapy. Adv Therap. 3(10):2000093.
  • Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science. 327(5962):167–170.
  • Hou T, Zeng W, Yang M, Chen W, Ren L, Ai J, Wu J, Liao Y, Gou X, Li Y, et al. 2020. Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19. PLoS Pathog. 16(8):e1008705.
  • Huang W, Yu L, Wen D, Wei D, Sun Y, Zhao H, Ye Y, Chen W, Zhu Y, Wang L, et al. 2020. A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection. EBioMedicine. 61:103036.
  • Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, Fusco D, Drouin A, Yin X, Hu T, et al. 2020. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 164:112316.
  • Hyman P, Abedon ST. 2010. Bacteriophage host range and bacterial resistance. Adv Appl Microbiol. 70:217–248.
  • Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. 1987. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol. 169(12):5429–5433.
  • Jackson JA, Kim EJ, Begley B, Cheeseman J, Harden T, Perez SD, Thomas S, Warshaw B, Kirk AD. 2011. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant. 11(10):2228–2234.
  • Jenson HB. 2011. Epstein-Barr virus. Pediatr Rev. 32(9):375–383; quiz 384.
  • Jiao J, Kong K, Han J, Song S, Bai T, Song C, Wang M, Yan Z, Zhang H, Zhang R, et al. 2021. Field detection of multiple RNA viruses/viroids in apple using a CRISPR/Cas12a-based visual assay. Plant Biotechnol J. 19(2):394–405.
  • Joyanta B, et al. 2017. A critical review on white spot syndrome virus (WSSV): A potential threat to shrimp farming in Bangladesh and some Asian countries. Int J Microbiol Mycol. 6(1):39–48.
  • Kaminski MM, Alcantar MA, Lape IT, Greensmith R, Huske AC, Valeri JA, Marty FM, Klämbt V, Azzi J, Akalin E, et al. 2020. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat Biomed Eng. 4(6):601–609.
  • Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F. 2019. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 14(10):2986–3012.
  • Khan H, Khan A, Liu Y, Wang S, Bibi S, Xu H, Liu Y, Durrani S, Jin L, He N, et al. 2019. CRISPR-Cas13a mediated nanosystem for attomolar detection of canine parvovirus type 2. Chin Chem Lett. 30(12):2201–2204.
  • Kunimasa K, Bando Y, Shiraishi M, Aizawa E, Nishino K, Tamiya M, Inoue T, Kuhara H, Kawachi H, Kuno K, et al. 2020. Development CRISPR-Cas12-based rapid EGFR mutation detection kit. JCO. 38(15_suppl):e13669–e13669.
  • Lau A, Ren CL, Lee LP. 2021. Critical review on where CRISPR meets molecular diagnostics. Prog Biomed Eng. 3(1):012001.
  • Lee RA, Puig HD, Nguyen PQ, Angenent-Mari NM, Donghia NM, McGee JP, Dvorin JD, Klapperich CM, Pollock NR, Collins JJ, et al. 2020. Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria. Proc Natl Acad Sci Usa. 117(41):25722–25731.
  • Lee SH, Yu J, Hwang G-H, Kim S, Kim HS, Ye S, Kim K, Park J, Park DY, Cho Y-K, et al. 2017. CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR. Oncogene. 36(49):6823–6829.
  • Li H, Bian C, Liao L, Li J, Zhao RC. 2011. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat. 126(3):565–575.
  • Li L, Li S, Wu N, Wu J, Wang G, Zhao G, Wang J. 2019. HOLMESv2: a CRISPR-Cas12b-assisted platform for nucleic acid detection and DNA methylation quantitation. ACS Synth Biol. 8(10):2228–2237.
  • Li S, Huang J, Ren L, Jiang W, Wang M, Zhuang L, Zheng Q, Yang R, Zeng Y, Luu LDW, et al. 2021. A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): application for the diagnosis of COVID-19. Talanta. 233:122591.
  • Li S-Y, Cheng Q-X, Wang J-M, Li X-Y, Zhang Z-L, Gao S, Cao R-B, Zhao G-P, Wang J. 2018. CRISPR-Cas12a-assisted nucleic acid detection. Cell Discov. 4(1):1–4.
  • Li Y, Li S, Wang J, Liu G. 2019. CRISPR/Cas systems towards next-generation biosensing. Trends Biotechnol. 37(7):730–743.
  • Li Y, Mansour H, Wang T, Poojari S, Li F. 2019. Naked-eye detection of grapevine red-blotch viral infection using a plasmonic CRISPR Cas12a assay. Anal Chem. 91(18):11510–11513.
  • Li Y, Zheng Y, Wu L, Li J, Ji J, Yu Q, Dai W, Feng J, Wu J, Guo C. 2021. Current status of ctDNA in precision oncology for hepatocellular carcinoma. J Exp Clin Cancer Res. 40(1):1–17.
  • Liang M, Li Z, Wang W, Liu J, Liu L, Zhu G, Karthik L, Wang M, Wang K-F, Wang Z, et al. 2019. A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules. Nat Commun. 10(1):1–9.
  • Liu R, He Y, Lan T, Zhang J. 2021. Installing CRISPR–Cas12a sensors in a portable glucose meter for point-of-care detection of analytes. Analyst. 146(10):3114–3120.
  • Liu Y, Xu H, Liu C, Peng L, Khan H, Cui L, Huang R, Wu C, Shen S, Wang S, et al. 2019. CRISPR-Cas13a nanomachine based simple technology for avian influenza A (H7N9) virus on-site detection. J Biomed Nanotechnol. 15(4):790–798.
  • Mahas A, Hassan N, Aman R, Marsic T, Wang Q, Ali Z, Mahfouz MM. 2021. LAMP-coupled CRISPR–Cas12a module for rapid and sensitive detection of plant DNA viruses. Viruses. 13(3):466.
  • Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS, Brouns SJJ, Charpentier E, Cheng D, Haft DH, Horvath P, et al. 2020. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 18(2):67–83.
  • Mojica FJM, Díez-Villaseñor C, García-Martínez J, Soria E. 2005. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 60(2):174–182.
  • Mustafa MI, Makhawi AM. 2021. SHERLOCK and DETECTR: CRISPR-Cas systems as potential rapid diagnostic tools for emerging infectious diseases. J Clin Microbiol. 59(3):e00745.
  • Myhrvold C, Freije CA, Gootenberg JS, Abudayyeh OO, Metsky HC, Durbin AF, Kellner MJ, Tan AL, Paul LM, Parham LA, et al. 2018. Field-deployable viral diagnostics using CRISPR-Cas13. Science. 360(6387):444–448.
  • Nguyen LT, Smith BM, Jain PK. 2020. Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection. Nat Commun. 11(1):1–13.
  • Ning B, Yu T, Zhang S, Huang Z, Tian D, Lin Z, Niu A, Golden N, Hensley K, Threeton B, et al. 2021. A smartphone-read ultrasensitive and quantitative saliva test for COVID-19. Sci Adv. 7(2):eabe3703.
  • Nunes DN, Dias-Neto E, Cardó-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, et al. 2015. Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch. Proc Natl Acad Sci U S A. 112(12):3770–3775.
  • Ooi KH, Liu MM, Tay JWD, Teo SY, Kaewsapsak P, Jin S, Lee CK, Hou J, Maurer-Stroh S, Lin W, et al. 2021. An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing. Nat Commun. 12(1):1–23.
  • Palaz F, Kalkan AK, Tozluyurt A, Ozsoz M. 2021. CRISPR-based tools: alternative methods for the diagnosis of COVID-19. Clin Biochem. 89:1–13.
  • Pardee K, Green AA, Takahashi MK, Braff D, Lambert G, Lee JW, Ferrante T, Ma D, Donghia N, Fan M, et al. 2016. Rapid, low-cost detection of Zika virus using programmable biomolecular components. Cell. 165(5):1255–1266.
  • Park JS, Hsieh K, Chen L, Kaushik A, Trick AY, Wang T‐H. 2021. Digital CRISPR/Cas‐assisted assay for rapid and sensitive detection of SARS‐CoV‐2. Adv Sci. 8(5):2003564.
  • Park KC, Gaze DC, Collinson PO, Marber MS. 2017. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 113(14):1708–1718.
  • Patchsung M, Jantarug K, Pattama A, Aphicho K, Suraritdechachai S, Meesawat P, Sappakhaw K, Leelahakorn N, Ruenkam T, Wongsatit T, et al. 2020. Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA. Nat Biomed Eng. 4(12):1140–1149.
  • Pourcel C, Salvignol G, Vergnaud G. 2005. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (Reading). 151(Pt 3):653–663.
  • Qin P, Park M, Alfson KJ, Tamhankar M, Carrion R, Patterson JL, Griffiths A, He Q, Yildiz A, Mathies R, et al. 2019. Rapid and fully microfluidic Ebola virus detection with CRISPR-Cas13a. ACS Sens. 4(4):1048–1054.
  • Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J. 2016. Cell-free circulating tumor DNA in cancer. Chin J Cancer. 35(1):1–9.
  • Ramachandran A, Huyke DA, Sharma E, Sahoo MK, Huang C, Banaei N, Pinsky BA, Santiago JG. 2020. Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proc Natl Acad Sci U S A. 117(47):29518–29525.
  • Ramachandran V, Weiland JJ, Bolton MD. 2021. CRISPR-based isothermal next-generation diagnostic method for virus detection in sugarbeet. Front Microbiol. 12:1760.
  • Raper AT, Stephenson AA, Suo Z. 2018. Functional insights revealed by the kinetic mechanism of CRISPR/Cas9. J Am Chem Soc. 140(8):2971–2984.
  • Rauch JN, Valois E, Solley SC, Braig F, Lach RS, Audouard M, Ponce-Rojas JC, Costello MS, Baxter NJ, Kosik KS, et al. 2021. A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material. J Clin Microbiol. 59(4):e02402–20.
  • Sastry KS, Zitter TA. 2014. Plant virus and viroid diseases in the tropics: volume 2: epidemiology and management. Dordrecht: Springer Science & Business Media.
  • Schübeler D. 2015. Function and information content of DNA methylation. Nature. 517(7534):321–326.
  • Sengupta, Pritam K, et al. 2003. DNA hypermethylation near the transcription start site of collagen α2 (I) gene occurs in both cancer cell lines and primary colorectal cancers. Cancer Res. 63.8:1789–1797.
  • Shah DH, Elder JR, Chiok KL, Paul NC. 2017. Genetic basis of Salmonella enteritidis pathogenesis in chickens. In: Producing safe eggs: microbial ecology of salmonella. London: Academic Press; p. 187–208.
  • Shan Y, Zhou X, Huang R, Xing D. 2019. High-fidelity and rapid quantification of miRNA combining crRNA programmability and CRISPR/Cas13a trans-cleavage activity. Anal Chem. 91(8):5278–5285.
  • Shen J, Zhou X, Shan Y, Yue H, Huang R, Hu J, Xing D. 2020. Sensitive detection of a bacterial pathogen using allosteric probe-initiated catalysis and CRISPR-Cas13a amplification reaction. Nat Commun. 11(1):1–10.
  • Shinoda H, Taguchi Y, Nakagawa R, Makino A, Okazaki S, Nakano M, Muramoto Y, Takahashi C, Takahashi I, Ando J, et al. 2021. Amplification-free RNA detection with CRISPR–Cas13. Commun Biol. 4(1):1–7.
  • Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, et al. 2015. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell. 60(3):385–397.
  • Slaymaker IM, Mesa P, Kellner MJ, Kannan S, Brignole E, Koob J, Feliciano PR, Stella S, Abudayyeh OO, Gootenberg JS, et al. 2019. High-resolution structure of Cas13b and biochemical characterization of RNA targeting and cleavage. Cell Rep. 26(13):3741–3751.
  • Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. 2020. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 76:71–76.
  • Sullivan TJ, Dhar AK, Cruz-Flores R, Bodnar AG. 2019. Rapid, CRISPR-based, field-deployable detection of white spot syndrome virus in shrimp. Sci Rep. 9(1):1–7.
  • Teng F, Guo L, Cui T, Wang X-G, Xu K, Gao Q, Zhou Q, Li W. 2019. CDetection: CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity. Genome Biol. 20(1):1–7.
  • Tsou J-H, Leng Q, Jiang F. 2020. A CRISPR test for rapidly and sensitively detecting circulating EGFR mutations. Diagnostics. 10(2):114.
  • Wang B, Wang R, Wang D, Wu J, Li J, Wang J, Liu H, Wang Y. 2019. Cas12aVDet: a CRISPR/Cas12a-based platform for rapid and visual nucleic acid detection. Anal Chem. 91(19):12156–12161.
  • Wang C, Liu M, Wang Z, Li S, Deng Y, He N. 2021. Point-of-care diagnostics for infectious diseases: From methods to devices. Nano Today. 37:101092.
  • Wang Q, Zhang B, Xu X, Long F, Wang J. 2018. CRISPR-typing PCR (ctPCR), a new Cas9-based DNA detection method. Sci Rep. 8(1):1–13.
  • Wang R, Qian C, Pang Y, Li M, Yang Y, Ma H, Zhao M, Qian F, Yu H, Liu Z, et al. 2021. opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection. Biosens Bioelectron. 172:112766.
  • Wang X, Chen S, Tang X, Lin D, Qiu P. 2019. Ultrasensitive detection of uric acid in serum of patients with gout by a new assay based on Pt@ Ag nanoflowers. RSC Adv. 9(63):36578–36585.
  • Wang X, Ji P, Fan H, Dang L, Wan W, Liu S, Li Y, Yu W, Li X, Ma X, et al. 2020. CRISPR/Cas12a technology combined with immunochromatographic strips for portable detection of African swine fever virus. Commun Biol. 3(1):1–8.
  • Wang X, Zhong M, Liu Y, Ma P, Dang L, Meng Q, Wan W, Ma X, Liu J, Yang G, et al. 2020. Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER. Sci Bull (Beijing). 65(17):1436–1439.
  • Wang Y, Li J, Li S, Zhu X, Wang X, Huang J, Yang X, Tai J. 2021. LAMP-CRISPR-Cas12-based diagnostic platform for detection of Mycobacterium tuberculosis complex using real-time fluorescence or lateral flow test. Microchim Acta. 188(10):1–9.
  • Wu X, Tay JK, Goh CK, Chan C, Lee YH, Springs SL, Wang DY, Loh KS, Lu TK, Yu H, et al. 2021. Digital CRISPR-based method for the rapid detection and absolute quantification of nucleic acids. Biomaterials. 274:120876.
  • Wu Y, Liu S-X, Wang F, Zeng M-S. 2019. Room temperature detection of plasma Epstein-Barr Virus DNA with CRISPR-Cas13. Clin Chem. 65(4):591–592.
  • Wu Y-C, Chen C-S, Chan Y-J. 2020. The outbreak of COVID-19: an overview. J Chin Med Assoc. 83(3):217–220.
  • Yuan C, Tian T, Sun J, Hu M, Wang X, Xiong E, Cheng M, Bao Y, Lin W, Jiang J, et al. 2020. Universal and naked-eye gene detection platform based on the clustered regularly interspaced short palindromic repeats/Cas12a/13a system. Anal Chem. 92(5):4029–4037.
  • Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, et al. 2015. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 163(3):759–771.
  • Zhang B, Wang Q, Xu X, Xia Q, Long F, Li W, Shui Y, Xia X, Wang J. 2018. Detection of target DNA with a novel Cas9/sgRNAs-associated reverse PCR (CARP) technique. Anal Bioanal Chem. 410(12):2889–2900.
  • Zhang F, Abudayyeh OO, Gootenberg JS. 2020. A protocol for detection of COVID-19 using CRISPR diagnostics. https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf
  • Zhang M, Eshraghian EA, Jammal OA, Zhang Z, Zhu X. 2021. CRISPR technology: The engine that drives cancer therapy. Biomed Pharmacother. 133:111007.
  • Zhao X, Zhang W, Qiu X, Mei Q, Luo Y, Fu W. 2020. Rapid and sensitive exosome detection with CRISPR/Cas12a. Anal Bioanal Chem. 412(3):601–609.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.